Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of a 6-month (± 14 days) dietary supplementation period with T1675,
a per os omega 3 and omega 6 polyunsaturated essential fatty acid dietary formulation, versus
placebo in patients with bilateral treated moderate dry eye syndrome